CN106689959A - Solid beverage for assisting blood glucose regulation - Google Patents
Solid beverage for assisting blood glucose regulation Download PDFInfo
- Publication number
- CN106689959A CN106689959A CN201710018695.XA CN201710018695A CN106689959A CN 106689959 A CN106689959 A CN 106689959A CN 201710018695 A CN201710018695 A CN 201710018695A CN 106689959 A CN106689959 A CN 106689959A
- Authority
- CN
- China
- Prior art keywords
- parts
- solid beverage
- oligosaccharide
- blood glucose
- oat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 34
- 239000007787 solid Substances 0.000 title claims abstract description 33
- 235000013361 beverage Nutrition 0.000 title claims abstract description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 7
- 239000008103 glucose Substances 0.000 title abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 16
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 15
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 15
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 14
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 13
- 235000013312 flour Nutrition 0.000 claims description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 12
- 239000003814 drug Substances 0.000 abstract description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract description 5
- 102000004877 Insulin Human genes 0.000 abstract description 5
- 108090001061 Insulin Proteins 0.000 abstract description 5
- 229940125396 insulin Drugs 0.000 abstract description 5
- 235000009811 Momordica charantia Nutrition 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract description 2
- 229940107187 fructooligosaccharide Drugs 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 description 8
- 239000000463 material Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- 244000302512 Momordica charantia Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 2
- 235000018365 Momordica dioica Nutrition 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 229940127003 anti-diabetic drug Drugs 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 229940122199 Insulin secretagogue Drugs 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000731396 Pueraria montana var. thomsonii Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 108010050181 aleurone Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 230000003694 hair properties Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000009654 wuzhi Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a solid beverage for assisting blood glucose regulation and belongs to the technical field of health-care foods. The solid beverage is prepared from the following components in parts by weight through mixing: 1-10 parts of chitosan oligosaccharide, 5-25 parts of oat-beta-glucan, 5-10 parts of xylo-oligosaccharide, 40-80 parts of fructooligosaccharide, 5-20 parts of Chinese yam powder, 5-10 parts of kudzu vine root powder and 5-10 parts of bitter gourd extract. The solid beverage for assisting blood glucose regulation, disclosed by the invention, is prepared from food raw materials and traditional Chinese medicine raw materials both used as medicines and foods; and the solid beverage can be used for assisting blood glucose regulation and can be used for reducing side effects caused by the fact that patients with diabetes mellitus usually orally take Western medicines and supplement insulin.
Description
Technical field
The present invention relates to technical field of health care food, it is more particularly to a kind of for hyperglycaemia, hyperlipemia health care and
The solid beverage of the auxiliary adjustment blood sugar of prevention.
Background technology
Diabetes are one group of metabolic diseases being characterized with hyperglycaemia.Hyperglycaemia be then due to defect of insulin secretion or
Its biological agent is damaged, or both have concurrently and cause.Diabetes are a kind of lifelong diseases, and its seriousness is the generation of complication
Rate is higher, and such as atherosclerosis, coronary heart disease, miocardial infarction, cerebral apoplexy, Lower-Extremity Ischemia or obturation (is also called diabetes
Macrovascular complications), DKA, renal failure, impotence, PVR and DPN etc., be to cause patient to lose work
Power, the lethal principal element for disabling.
At present, the mode for the treatment of diabetes is mainly by oral single Insulin secretagogues or enzyme inhibitor this species
Type antidiabetic drug or the blood sugar using insulin, or both and for controlling diabetic, or even also pass through hunger cure, hand
The modes such as art treatment control the state of an illness of diabetic.The therapeutic modality of these " only obtain and do not supplement ", side effect is big, makes patient
Dependence is produced to medicine, is got off for a long time, not only aggravate the secretion burden of ill pancreas islet, cause islet cell failure, medicine after
Hair property failure, also badly damaged various body organs trigger or aggravate the complication state of an illness.
The content of the invention
A kind of solid drink of auxiliary adjustment blood sugar is provided it is an object of the invention to overcome the deficiencies in the prior art part
Material, be made up of raw-food material and integration of drinking and medicinal herbs Chinese medicine material, can auxiliary adjustment blood sugar, reduce diabetes patient's long-term taking Western medicine and
The side effect of supplementation with insulin.
In order to solve the above technical problems, the technical scheme is that：
A kind of solid beverage of auxiliary adjustment blood sugar, is the solid beverage being mixed by following components in parts by weight：Shell
Oligosaccharides 1-10 parts, oat-beta glucan 5-25 parts, xylo-oligosaccharide 5-10 parts, FOS 40-80 parts, yam flour 5-20 parts, Pueraria lobota
5-10 parts, Bitter Melon P.E 5-10 parts of root powder.
Wherein it is preferred to, a kind of solid beverage of auxiliary adjustment blood sugar is mixed by following components in parts by weight
Solid beverage：Chitosan oligosaccharide 4-6 parts, oat-beta glucan 10-20 parts, xylo-oligosaccharide 6-8 parts, FOS 50-70 parts, Chinese yam
Powder 10-15 parts, kudzu-vine root powder 6-8 parts, Bitter Melon P.E 6-8 parts.
Wherein it is preferred to, a kind of solid beverage of auxiliary adjustment blood sugar is mixed by following components in parts by weight
Solid beverage：5 parts of chitosan oligosaccharide, 15 parts of oat-beta glucan, 7 parts of xylo-oligosaccharide, 60 parts of FOS, 12 parts of yam flour, the root of kudzu vine
7 parts of powder, 7 parts of Bitter Melon P.E.
Chitosan oligosaccharide is called Chitosan poly oligosaccharide, chitosan oligomer, is that through special biological enzyme technology (shitosan is also had into useization
Learn degraded, the report of microwave degradation technology) a kind of degree of polymerization for obtaining of degrading oligosaccharide product between 2~20, molecular weight≤
3200Da, is the water-soluble preferable, low molecular weight product that function is big, bioactivity is high.Chitosan oligosaccharide is by shitosan depolymerization
It is made, is chitin, the upgrading products of shitosan product, with the superiority that shitosan is incomparable.To the immune tune of human body
Section, antitumor, reducing blood lipid, regulation blood sugar, improvement liver and cardio-pulmonary function and other different physiological roles important roles.
β in oat-(1 → 3,1 → 4) glucan abbreviation oat-beta glucan, is to be present in oat endosperm and aleurone
A kind of SNSP of cell membrane.It is bonded by monomer β-D- glucopyranoses by β-(1 → 3) and β-(1 → 4) glucosides
A kind of high molecular polymer for picking up to be formed.Oat food has the effect of reduction blood fat and serum cholesterol, to prevention and
Treatment cardiovascular and cerebrovascular disease and diabetes have important effect.Beta glucan is to the glucose level in blood, hormone response, dimension
The biological effect of raw element and mineral matter has certain adjustment effect, has positive role to preventing colon cancer.
Xylo-oligosaccharide, also known as wooden chitosan oligosaccharide, is the functional polyalkylene being combined into β-Isosorbide-5-Nitrae glycosidic bond by 2-7 xylose molecule
Close sugar.With unique advantage compared with the soyabean oligosaccharides used by usual people, FOS, oligoisomaltose etc., it
The proliferation activity of intestinal bifidobacteria can be selectively promoted.Its bifidobacterium factor functional is 10-20 times of other polymerization carbohydrates.
Played a role in low-energy food, those are met to greatest extent and is liked sweets and is worried wanting for the people of diabetes and obesity
Ask, thus diabetes patient, adiposis patient and hypoglycemosis can trust per capita it is edible.
FOS, also known as fructooligosaccharide, is by the fruit in β (2-1) glycosidic bond and sucrose by 1~3 fructosyl
Glycosyl combines the mixture of ketose, Nystose and the GF4 of generation etc..FOS is a kind of natural active products
Matter.Sugariness is 0.3-0.6 times of sucrose.Both the pure sweetening characteristics of sucrose had been maintained, but it is salubriouser than sucrose sweet taste.It is have to adjust
Section gut flora, breeds Bifidobacterium, promotes the absorption of calcium, adjusts the new of the healthcare functions such as blood fat, immunological regulation, anti-caries tooth
Sweetener, is described as after additive of new generation-growth-promoting material most potential after the antibiotic epoch.
Chinese yam nature and flavor are sweet, put down, enter spleen, lung, kidney channel.《Medicine reflects》：" weakness is controlled, general debility is treated.QI invigorating power, moistens
Skin.Muscle long, and strengthening the bones and muscles.Except fever and chills perverse trend, but head urticaria wind is dizzy.Happy key is clever, puckery to let out cunning through pipe." clinic should
For tonifying spleen and stomach, beneficial lung kidney and reinforcing both QI and YIN.For lassitude, deficiency of food diarrhea, leukorrhea, chronic cough, pass out semen, the card such as quench one's thirst.Bosom
The cultivation history of the existing thousands of years of Chinese yam, produces the most famous with Henan Province Wuzhi County, joins also known as bosom.RHIIZOMA DIOSCOREAE from Henan of China Main Ingredients and Appearance contains
Saponin(e, mucilaginous substance, choline, Chinese yam alkali, starch, glycoprotein, free amino acid, polyphenol oxidase, acerin, vitamin C, in mucus
Containing mannosan, phytic acid, 3,4- hydroxyphenethylamines, carbonaceous, tannin, allantoin, iodine matter, 16 kinds of amino acid, also containing iron,
The various trace elements such as copper, zinc, manganese, calcium.With immunological regulation, resist oxygen lack, anti-aging, hypoglycemic effect.
Kudzu-vine root powder, Chinese medicine name.It is legume pueraria lobata Pueraria lobata (Willd.) Ohwi, sweet kudzu
The root tuber of P.thomsonii Benth. clear starch for taking through water mill.With antipyretic relieving restlessness, the effect of promoting the production of body fluid to quench thirst, for being tired of
Heat, thirsty, drunk, larynx numbness, boil.
Balsam pear, is the fruit of cucurbitaceous plant balsam pear Momordica charantia L..Generally cultivate in China north and south.
The effect of heat, improving eyesight, removing toxic substances is washed with driving away summer heat.It is usually used in hot summer weather polydipsia, quenches one's thirst, cute conjunctivitis pain, dysentery, sore and toxic.
Yam flour, kudzu-vine root powder in the present invention and three kinds of raw materials synergies of balsam pear, with reduction blood fat, regulation blood sugar,
The effects such as anti-aging, immune enhancing, chitosan oligosaccharide, oat-beta glucan, xylo-oligosaccharide and FOS in invention formula
It is sweet with cooling taste, it is not necessary to the promotion of insulin, and cell membrane can be passed through, the nutrition as tissue, and can make liver
Hepatic glycogen increases.Both the mouthfeel of this product had been improved, and the diabetes patient having a sweet tooth can be allowed to be satisfied with, had sweet taste.
With the solid beverage of the auxiliary adjustment blood sugar in the present invention, there is diabetic history (blood glucose value 200- to 50~65 years old
Complete rest 400mg/dl) and half-day rest patient, give twice daily, and each 30g takes solid beverage of the present invention, through 6-9
After individual month, frequent micturition, four limbs are aching and limp, and the symptom such as weak is improved all over the body, can recover normal work, and energy is fine, blood glucose value
75% for declining, less than the simple person that takes antidiabetic drug.Thirsty and hunger disappears substantially, hypourocrinia, and reaching for having is normal, high
The cholesterol of blood fat disease patient, triglycerides are decreased obviously, evident in efficacy, and are had no toxic side effect, and therapeutic effect is made us
It is satisfied.Therefore the present invention is drunk for a long time, it is extremely beneficial to diabetes, the health of hyperlipemic patients.
This prescription is all made up of raw-food material and integration of drinking and medicinal herbs Chinese medicine material, can auxiliary adjustment blood sugar, reduction diabetes
The side effect of people's long-term taking Western medicine and supplementation with insulin.
Beneficial effect of the present invention：
Solid beverage of the present invention has promotion human body glycometabolism and is allowed to balance, and protects and repairing islet cells, reverses simultaneously
Hair disease, allows blood-sugar content gradually to tend to normal, can effectively control blood sugar and reduce blood sugar, is particularly suitable for diabetic's drink
With normal person drinks also good nutrition health-care functions.
Specific embodiment
The technical scheme in the embodiment of the present invention is clearly and completely described below, it is clear that described embodiment
Only a part of embodiment of the invention, rather than whole embodiments.Based on the embodiment in the present invention, the common skill in this area
The every other embodiment that art personnel are obtained under the premise of creative work is not made, belongs to the model of present invention protection
Enclose.
Embodiment 1
The present embodiment provides a kind of solid beverage of auxiliary adjustment blood sugar, is mixed by following components in parts by weight
Solid beverage：5 parts of chitosan oligosaccharide, 15 parts of oat-beta glucan, 7 parts of xylo-oligosaccharide, 60 parts of FOS, 12 parts of yam flour, the root of kudzu vine
7 parts of powder, 7 parts of Bitter Melon P.E.
Embodiment 2
The present embodiment provides a kind of solid beverage of auxiliary adjustment blood sugar, is mixed by following components in parts by weight
Solid beverage：1 part of chitosan oligosaccharide, 25 parts of oat-beta glucan, 5 parts of xylo-oligosaccharide, 80 parts of FOS, 5 parts of yam flour, the root of kudzu vine
10 parts of powder, 5 parts of Bitter Melon P.E.
Embodiment 3
The present embodiment provides a kind of solid beverage of auxiliary adjustment blood sugar, is mixed by following components in parts by weight
Solid beverage：10 parts of chitosan oligosaccharide, 5 parts of oat-beta glucan, 10 parts of xylo-oligosaccharide, 40 parts of FOS, 20 parts of yam flour, Pueraria lobota
5 parts of root powder, 10 parts of Bitter Melon P.E.
Embodiment 4
The present embodiment provides a kind of solid beverage of auxiliary adjustment blood sugar, is mixed by following components in parts by weight
Solid beverage：4 parts of chitosan oligosaccharide, 20 parts of oat-beta glucan, 6 parts of xylo-oligosaccharide, 70 parts of FOS, 10 parts of yam flour, the root of kudzu vine
8 parts of powder, 6 parts of Bitter Melon P.E.
Embodiment 5
The present embodiment provides a kind of solid beverage of auxiliary adjustment blood sugar, is mixed by following components in parts by weight
Solid beverage：6 parts of chitosan oligosaccharide, 10 parts of oat-beta glucan, 8 parts of xylo-oligosaccharide, 50 parts of FOS, 15 parts of yam flour, the root of kudzu vine
6 parts of powder, 8 parts of Bitter Melon P.E.
Presently preferred embodiments of the present invention is the foregoing is only, is not intended to limit the invention, it is all in essence of the invention
Within god and principle, any modification, equivalent substitution and improvements made etc. should be included within the scope of the present invention.
Claims (3)
1. a kind of solid beverage of auxiliary adjustment blood sugar, it is characterised in that be the solid being mixed by following components in parts by weight
Beverage：Chitosan oligosaccharide 1-10 parts, oat-beta glucan 5-25 parts, xylo-oligosaccharide 5-10 parts, FOS 40-80 parts, yam flour 5-
20 parts, kudzu-vine root powder 5-10 parts, Bitter Melon P.E 5-10 parts.
2. the solid beverage of a kind of auxiliary adjustment blood sugar according to claim 1, it is characterised in that be by following weight parts
The solid beverage that is mixed of component：Chitosan oligosaccharide 4-6 parts, oat-beta glucan 10-20 parts, xylo-oligosaccharide 6-8 parts, it is oligomeric
Fructose 50-70 parts, yam flour 10-15 parts, kudzu-vine root powder 6-8 parts, Bitter Melon P.E 6-8 parts.
3. the solid beverage of a kind of auxiliary adjustment blood sugar according to claim 1, it is characterised in that be by following weight parts
The solid beverage that is mixed of component：5 parts of chitosan oligosaccharide, 15 parts of oat-beta glucan, 7 parts of xylo-oligosaccharide, FOS 60
Part, 12 parts of yam flour, 7 parts of kudzu-vine root powder, 7 parts of Bitter Melon P.E.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710018695.XA CN106689959A (en) | 2017-01-10 | 2017-01-10 | Solid beverage for assisting blood glucose regulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710018695.XA CN106689959A (en) | 2017-01-10 | 2017-01-10 | Solid beverage for assisting blood glucose regulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106689959A true CN106689959A (en) | 2017-05-24 |
Family
ID=58907284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710018695.XA Pending CN106689959A (en) | 2017-01-10 | 2017-01-10 | Solid beverage for assisting blood glucose regulation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106689959A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107173814A (en) * | 2017-06-19 | 2017-09-19 | 江西天帝仁医药科技有限公司 | Chitin oligo saccharide functional health nutraceutical |
| CN107307417A (en) * | 2017-06-17 | 2017-11-03 | 深圳市领治医学科技有限公司 | A kind of type 2 diabetes patient's nutriment |
| CN107467461A (en) * | 2017-07-27 | 2017-12-15 | 安徽恋尚你食品有限公司 | A kind of QI invigorating health type solid beverage |
| CN107495362A (en) * | 2017-08-02 | 2017-12-22 | 深圳市领治医学科技有限公司 | A kind of Diabetic Nephropathy patients nutriment |
| CN108523134A (en) * | 2018-05-04 | 2018-09-14 | 珠海津之敦医药科技有限公司 | A kind of avenabeta glucosan Orally administered composition and its application |
| CN109170461A (en) * | 2018-09-03 | 2019-01-11 | 溧阳市迪贝乐生物科技有限公司 | A kind of oligofructose solid beverage and preparation method thereof |
| CN110839805A (en) * | 2019-11-22 | 2020-02-28 | 坤承(北京)健康管理有限公司 | Plant solid beverage |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048218A (en) * | 2009-10-30 | 2011-05-11 | 常堡同 | Beverage for reducing blood sugar, blood pressure and blood fat and production method thereof |
| CN102948863A (en) * | 2011-08-25 | 2013-03-06 | 河北农业大学 | Production technology of transparent tartary buckwheat high-fiber beverage |
| CN105341614A (en) * | 2015-12-17 | 2016-02-24 | 重庆都好生物科技有限公司 | Small molecule peptide solid drink |
| CN105961960A (en) * | 2016-02-25 | 2016-09-28 | 合肥众得乐食品有限公司 | Bitter gourd and rhizoma polygonati odorati drink having efficacy of high blood glucose regulation and manufacturing method of drink |
-
2017
- 2017-01-10 CN CN201710018695.XA patent/CN106689959A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048218A (en) * | 2009-10-30 | 2011-05-11 | 常堡同 | Beverage for reducing blood sugar, blood pressure and blood fat and production method thereof |
| CN102948863A (en) * | 2011-08-25 | 2013-03-06 | 河北农业大学 | Production technology of transparent tartary buckwheat high-fiber beverage |
| CN105341614A (en) * | 2015-12-17 | 2016-02-24 | 重庆都好生物科技有限公司 | Small molecule peptide solid drink |
| CN105961960A (en) * | 2016-02-25 | 2016-09-28 | 合肥众得乐食品有限公司 | Bitter gourd and rhizoma polygonati odorati drink having efficacy of high blood glucose regulation and manufacturing method of drink |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107307417A (en) * | 2017-06-17 | 2017-11-03 | 深圳市领治医学科技有限公司 | A kind of type 2 diabetes patient's nutriment |
| CN107173814A (en) * | 2017-06-19 | 2017-09-19 | 江西天帝仁医药科技有限公司 | Chitin oligo saccharide functional health nutraceutical |
| CN107467461A (en) * | 2017-07-27 | 2017-12-15 | 安徽恋尚你食品有限公司 | A kind of QI invigorating health type solid beverage |
| CN107495362A (en) * | 2017-08-02 | 2017-12-22 | 深圳市领治医学科技有限公司 | A kind of Diabetic Nephropathy patients nutriment |
| CN108523134A (en) * | 2018-05-04 | 2018-09-14 | 珠海津之敦医药科技有限公司 | A kind of avenabeta glucosan Orally administered composition and its application |
| CN108523134B (en) * | 2018-05-04 | 2021-12-24 | 珠海津之敦医药科技有限公司 | Oat beta-glucan oral composition and application thereof |
| CN109170461A (en) * | 2018-09-03 | 2019-01-11 | 溧阳市迪贝乐生物科技有限公司 | A kind of oligofructose solid beverage and preparation method thereof |
| CN110839805A (en) * | 2019-11-22 | 2020-02-28 | 坤承(北京)健康管理有限公司 | Plant solid beverage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106689959A (en) | Solid beverage for assisting blood glucose regulation | |
| CN104432084B (en) | A kind of conditioning powder and its production and use | |
| CN104026446B (en) | A kind of it is suitable for nutritional meal replacement powder that hyperglycemia population takes and preparation method thereof | |
| CN106983052A (en) | A kind of solid beverage of auxiliary hyperglycemic and preparation method thereof | |
| CN106666312A (en) | Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof | |
| CN103734751B (en) | A kind of composite dietary and method for making thereof | |
| CN106616187A (en) | Solid beverage capable of assisting to lower hypertension, hyperglycemia and hyperlipidemia | |
| CN109966417A (en) | A kind of solid beverage for diabetic population | |
| CN106135797A (en) | A kind of alimentation composition contributing to regulation blood glucose and preparation method thereof | |
| CN101589801B (en) | Process for manufacturing red ginseng honey slice | |
| CN101168710B (en) | Eucommia bark wine and preparation method thereof | |
| CN106036342A (en) | Dietary supplement solid beverage suitable for diabetic population and preparation method of dietary supplement solid beverage | |
| CN109007856A (en) | The meal replacement powder and preparation method that a kind of suitable hypertension, hyperlipidemia, hyperglycemia and people with high uric acid are taken | |
| CN105148252A (en) | Compound blood glucose reducing preparation | |
| CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
| CN102113534B (en) | Moon cake with function of treating diabetes and preparation method thereof | |
| CN101507800A (en) | Ludisia discolor and pumpkin composite health care product capable of reducing blood sugar and preparation method thereof | |
| CN102987206A (en) | Composition capable of reducing blood glucose | |
| CN102511616A (en) | Low-energy candy containing natural ginseng and production method thereof | |
| CN105707681A (en) | Supermicro black fungus nutrient porridge with blood sugar reducing function and making method thereof | |
| CN109043553A (en) | A kind of Special food and preparation method thereof that patients with gestational diabetes is edible | |
| CN104543767A (en) | Blood glucose-reduction dieto-therapeutic noodle and preparation method thereof | |
| CN111165709A (en) | Solid beverage with blood sugar control function and preparation method thereof | |
| CN102640922B (en) | Black-and-white nutritional health-care rice for reducing blood sugar and preparation method thereof | |
| CN104054788A (en) | Celery healthcare biscuit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170524 |